Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution, in real time, to depths of 1 mm or more.

Our breakthrough technology enables in-vivo capture, visualization and measurement of biological details that are too small to be seen with ultrasound, and too deep for conventional microscopy.

Our current product range includes the VivoSight OCT scanner with hand-held probe, principally for dermal applications, and the EX1301 OCT Microscope, for laboratory applications. We are also developing more products with other types of probe.

Multi-Beam OCT has very many potential applications. Our VivoSight scanner is approved for clinical use in Europe, has 510(k) clearance in the USA, and is currently undergoing trials at multiple sites worldwide to assess its potential in enabling earlier and less invasive diagnosis and treatment of skin cancer. We also expect it to be of great value to analyse many other skin conditions, and for the rapid, accurate measurement of skin properties for non-clinical applications.

Please browse our website to find out more about Multi-Beam OCT, Michelson Diagnostics, our products and their applications.

Contact us NOW if you think Multi-Beam OCT could be of value in YOUR application